glp-1 weight gain after stopping In recent years, medications have transformed obesity treatment, producing unprecedented amounts of loss in clinical trials. But they come with an important challenge... What happens when people stop taking them? GLP-1 Care Track: No weight
Description
National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Ro, the leading direct-to-patient healthcare company, announced today that it is working with Novo Nordisk on the nationwide launch of the new Wegovy pill

Find GLP-1 providers that help with insurance and prior authorization in 2026 the fastest path to a low copay on Wegovy, Zepbound and Ozempic

The Active Ingredient: Amarasate (Am-ar-eh-sate) is an extract from hops
A government-approved expert panel recommended that the nation's drug regulator approve the import and sale of Mounjaro